K

+ Studies in 2000-2009 List

KIDNEYS +


KIDNEYS
Cannabinoid Receptor 1 Blockade Ameliorates Albuminuria in Experimental Diabetic Nephropathy (full–2010) http://diabetes.diabetesjournals.org/content/59/4/1046.full?sid=0bc8e3fa-5275-4b19-8acc-4aec5dfac384
Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2869084/?toolubmed
Expression of cannabinoid receptors in human kidney (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20607655
Cannabidiol Attenuates Cisplatin-Induced Nephrotoxicity by Decreasing Oxidative/Nitrosative Stress, Inflammation, and Cell Death (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2682269/
Pharmacology of GPR55 in yeast and identification of GSK494581A as a mixed-activity glycine transporter subtype 1 inhibitor and GPR55 agonist (full–2011) http://jpet.aspetjournals.org/content/337/1/236.long
Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062638/
Protective Role of Cannabinoid Receptor Type 2 in a Mouse Model of Diabetic Nephropathy (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161308/
Distinctive effects of plant protein sources on renal disease progression and associated cardiac hypertrophy in experimental kidney disease (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21294251
Is there a legitimate role for the therapeutic use of cannabinoids for symptom management in chronic kidney disease? (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21269798
Cannabinoid hyperemesis syndrome inducing acute prerenal failure and electrolyte disturbance (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21877303
β-Caryophyllene ameliorates cisplatin-induced nephrotoxicity in a cannabinoid 2 receptor-dependent manner (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3312970/
AKI Associated with Synthetic Cannabinoids: A Case Series (full–2012) http://www.ncbi.nlm.nih.gov/pubmed/23243266
Cannabidiol treatment ameliorates ischemia/reperfusion renal injury in rats (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22877651
Outbreak of kidney failure in Wyoming linked to “Spice” (news–2012) http://www.reuters.com/article/2012/03/03/us-spice-illness-wyoming-idUSTRE82204T20120303
Wyoming kidney failure outbreak linked to designer ‘blueberry spice’ drug, aka ‘legal marijuana’ (news–2012) http://www.naturalnews.com/035181_spice_recreational_drugs_kidney_failure.html
Blueberry “spice” in Wyoming linked to cases of renal failure (news–2012) http://www.thepoisonreview.com/2012/03/03/blueberry-spice-in-wyoming-linked-to-cases-of-renal-failure/
New health concerns about ‘fake pot’ in US (news – 2012) http://medicalxpress.com/news/2012-03-health-fake-pot.html
top
Cannabinoid Receptor 2 Expression in Human Proximal Tubule Cells is Regulated by Albumin Independent of ERK1/2 Signaling (full–2013) http://www.karger.com/Article/Pdf/354529
Acute Kidney Injury Associated with Synthetic Cannabinoid Use — Multiple States, 2012 (report–2013) http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6206a1.htm
Cannabinoid Receptors as Therapeutic Targets for Dialysis-Induced Peritoneal Fibrosis (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23296044
First Metabolic Profile of XLR-11, a Novel Synthetic Cannabinoid, Obtained by Using Human Hepatocytes and High-Resolution Mass Spectrometry (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24014837
Synthetic Marijuana Dangerous for Kidneys (news–2013) http://www.sciencedaily.com/releases/2013/02/130208124553.htm
Synthetic Marijuana Harms Kidneys of 16 Users, CDC Reports (news–2013) http://news.yahoo.com/synthetic-marijuana-harms-kidneys-16-users-cdc-reports-170208780.html
Synthetic drugs carry risk of kidney damage (news–2013) http://www.stuff.co.nz/timaru-herald/news/8558914/Synthetic-drugs-carry-risk-of-kidney-damage
Nephrotoxic effects of designer drugs: synthetic is not better! (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24662435
Deficiency of cannabinoid receptor of type 2 worsens renal functional and structural abnormalities in streptozotocin-induced diabetic mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24827776
Nephrotoxic Effects of Common and Emerging Drugs of Abuse (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25035273
Common polymorphism in the cannabinoid type 1 receptor gene (CNR1) is associated with microvascular complications in type 2 diabetes (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24075694
Acute kidney injury associated with smoking synthetic cannabinoid (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25089722
Severe rhabdomyolysis and intracranial hemorrhage associated with synthetic cannabinoid: a case report (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25179201
A case of acute cerebral ischemia following inhalation of a synthetic cannabinoid (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25241766
Inflammation in diabetic nephropathy: moving toward clinical biomarkers and targets for treatment (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25273317
Therapeutic Potential of Cannabinoids in Counteracting Chemotherapy-induced Adverse Effects: An Exploratory Review (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25504799
The Endocannabinoid System in Renal Cell: Regulation of Na+ Transport by CB1 Receptors Through Distinct Cell Signaling Pathways (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25537261
Elevated CB1 and GPR55 receptor expression in proximal tubule cells and whole kidney exposed to diabetic conditions (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25545857
High-throughput salting-out assisted liquid-liquid extraction with acetonitrile for the determination of anandamide in plasma of hemodialysis patients with liquid chromatography tandem mass spectrometry (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25622579
High-throughput salting-out assisted liquid-liquid extraction with acetonitrile for the determination of anandamide in plasma of hemodialysis patients with liquid chromatography tandem mass spectrometry (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25622579
top
Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological Insights and Potent Clinical Biomarker of Metabolic and Cardiovascular Diseases (full-2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315049/
Overexpression of g-protein-coupled receptor 40 enhances the mitogenic response to epoxyeicosatrienoic acids (full-2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0113130
High-throughput salting-out assisted liquid-liquid extraction with acetonitrile for the determination of anandamide in plasma of hemodialysis patients with liquid chromatography tandem mass spectrometry (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25622579
Urinary early kidney injury molecules in children with beta-thalassemia major (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25656833
Chronic administration with AM251 improves albuminuria and renal tubular structure in obese rats (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25804605
The effect of endocannabinoid system in ischemia-reperfusion injury: a friend or a foe? (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25936364
Synthetic Cannabinoids (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26132518 Enhanced vasorelaxation effect of endogenous anandamide on thoracic aorta in renal vascular hypertension rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26173564
The endocannabinoid system in renal cell: Regulation of Na+ transport by CB1 receptors through distinct cell signaling pathways (abst-2015)
http://www.ncbi.nlm.nih.gov/pubmed/26177675
Novel Triazolopyrimidine-Derived Cannabinoid Receptor 2 Agonists As Potential Treatment for Inflammatory Kidney Diseases (abst-2015)
http://www.ncbi.nlm.nih.gov/pubmed/26228928
Synthetic pot linked to kidney injury (news-2015) http://www.newschannel10.com/story/28652118/synthetic-pot-linked-to-kidney-injury
top


Advertisements